Experiences and perspectives of individuals accessing CAR-T cell therapy: A qualitative analysis of online Reddit discussions

被引:8
|
作者
Jenei, Kristina [1 ]
Burgess, Michael [2 ,3 ]
Peacock, Stuart [4 ,5 ,6 ]
Raymakers, Adam J. N. [4 ,5 ,6 ]
机构
[1] Univ British Columbia, Sch Populat & Publ Hlth, 2206 East Mall, Vancouver, BC V6T 1Z3, Canada
[2] Univ British Columbia, W Maurice Young Ctr Appl Eth, Sch Populat & Publ Hlth, Provosts Off, Vancouver, BC, Canada
[3] Univ British Columbia, W Maurice Young Ctr Appl Eth, Sch Populat & Publ Hlth, Provosts Off, Kelowna, BC, Canada
[4] Canadian Ctr Appl Res Canc Control CC ARCC, Vancouver, BC, Canada
[5] BC Canc, Canc Control Res, Vancouver, BC, Canada
[6] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC, Canada
来源
JOURNAL OF CANCER POLICY | 2021年 / 30卷
关键词
Cancer care; Patient experiences; Immuno-oncology; car-t; Adoptive cell therapy; Cancer policy; Patient-centred care; Health technology assessment; Reimbursement recommendations;
D O I
10.1016/j.jcpo.2021.100303
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Introduction: Several chimeric antigen receptor (CAR-T) T-cell therapies have been approved for use for haematological malignancies. Despite known safety, access, and cost issues, little is known about how patients and caregivers understand novel treatments such as CAR-T and their associated uncertainties. Methods: We gathered data from Reddit, an online public social media site. We performed a keyword search in three relevant subreddit threads: r/cancer, r/lymphoma, r/leukemia. We systematically extracted threads and associated comments and reviewed against our inclusion criteria. Results: We identified a total of 186 posts and 87 were included in the qualitative analysis from March 1, 2013, to April 15, 2021. Qualitative content analysis was used to identify themes. Of those excluded, 88 contained discussions of other immunotherapies and 11 were scientific profiles. We identified four themes: 1) navigating uncertainty with community, 2) finding a cure, 3) managing treatment-related uncertainties, and 4) overcoming uncertainties related to access. We found patients experience numerous barriers when seeking access to novel therapeutics, such as CAR-T therapies. Conclusions: The perceptions and struggles of patients and their families are relevant for developing technology assessments that are sensitive to patient experiences, as well as to inform policies for equitable resource allocation. Policy summary: Our study underscores the importance of balanced decision making between patients and physicians to ensure patients understand the risk and benefits of cancer treatments. Study investigators might evaluate trial participants based on patient demographics to ensure equitable access to studies for individuals in settings where internet access is less common.
引用
收藏
页数:4
相关论文
共 50 条
  • [21] Nonlinear dynamics of CAR-T cell therapy
    Fassoni, Artur C.
    Braga, Denis C.
    CHAOS SOLITONS & FRACTALS, 2025, 191
  • [22] CAR-T Cell Therapy: Challenges and Optimization
    Luo, Mei
    Zhang, Hongchang
    Zhu, Linnan
    Xu, Qumiao
    Gao, Qianqian
    CRITICAL REVIEWS IN IMMUNOLOGY, 2021, 41 (01) : 77 - 87
  • [23] A Theranostic Approach for CAR-T Cell Therapy
    Weber, Wolfgang A.
    Varasteh, Zohreh
    Fritschle, Katja
    Morath, Volker
    CLINICAL CANCER RESEARCH, 2022, 28 (24) : 5241 - 5243
  • [24] Reactions Related to CAR-T Cell Therapy
    Miao, Lele
    Zhang, Zhengchao
    Ren, Zhijian
    Li, Yumin
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [25] New development in CAR-T cell therapy
    Wang, Zhenguang
    Wu, Zhiqiang
    Liu, Yang
    Han, Weidong
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 10
  • [26] New development in CAR-T cell therapy
    Zhenguang Wang
    Zhiqiang Wu
    Yang Liu
    Weidong Han
    Journal of Hematology & Oncology, 10
  • [27] CAR-T Cell Therapy for PTLD: Analysis of CAR-T Product, Engraftment, and Outcomes in Patients Receiving Parallel Immunosuppression
    Panopoulou, Aikaterini
    Mehra, Vedika
    Cwynarski, Kate
    Morley-Smith, Andrew
    Hwang, Angela
    O'Reilly, Maeve
    Roddy, Harriet
    Roddie, Claire
    EJHAEM, 2025, 6 (01):
  • [28] CAR-T Cell Therapy for HIV Cure
    Salgado, Maria
    VIRUSES-BASEL, 2023, 15 (09):
  • [29] CAR-T cell therapy and infection: a review
    Bupha-Intr, Olivia
    Haeusler, Gabrielle
    Chee, Lynette
    Thursky, Karin
    Slavin, Monica
    Teh, Benjamin
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2021, 19 (06) : 749 - 758
  • [30] CAR-T Cell Therapy for Follicular Lymphomas
    Testa, Ugo
    D'Alo, Francesco
    Pelosi, Elvira
    Castelli, Germana
    Leone, Giuseppe
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2024, 16 (01)